Call runs ahead of the accounts: the business management describes is already operating beyond the period it is reportin
The model's full reasoning — Q1 2024 call → NOWe need answer only YES or NO. Need analyze transcript for gap between trailing reported period and current operating level. Management describes Q1 FY24 results, but also many ongoing developments. Need see if management's own words convey present already busier than print, and management treats reported numbers as behind business. Key points: Q1 revenue $78M, growth 6%, MedTech 13%. NanoKnife grew 36%, Auryon 26%, etc. But management highlights milestones: PRESERVE enrollment completed (final patient treated in Q1), APEX PE >75% enrolled, breakthrough designation for AngioVac, Auryon CE Mark expected, etc. Are these "already real" current business? They are clinical studies, regulatory milestones, not necessarily revenue. But also "NanoKnife business performed very well and grew approximately 36% during first quarter" - that's in period. Mechanical thrombectomy declined 6%, but AngioVac grew sequentially. They say "we believe steps are gaining traction." Not necessarily gap. Question: "clear gap between trailing period being reported and level at which business is already operating right now" such that management spends call describing company already moved beyond results. Need see if management says current activity/run-rate above reported figures. They give guidance for FY24, no explicit "current run-rate higher." They mention backlog $3.3M. They mention Q1 cash utilization highest. They mention "we are seeing improvements here during first quarter, although there's still more to come." That's normal. Potential: They discuss "PRESERVE study final patient enrolled" - that's clinical trial, not revenue. They discuss "APEX PE study now more than 75% enrolled" - not current business. They discuss "Auryon platform up 26%" - in period. They discuss "international businesses grew 26%" - in period. They discuss "ports grew 22%" - in period. So reported period already includes these. But maybe there is a gap: They say "NanoKnife growth was strong again internationally... strong U.S. growth driven by continuing interest... We believe NanoKnife has potential..." That's future. They say "We look forward to completing enrollment soon and after 30 day follow-up... expect data to support PE indication around end calendar Q2 2024." That's future. They say "We expect to finalize study design in Q2." Future.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
BFI · Q3 2021 → YESThe question is whether there's a clear gap between the trailing period being reported (Q3 2021) and the current operating level, as told by management. YES The transcript shows management treating the Q3 results as trailing behind the combined company's current scale. Ian Baines opens by noting the November 3 acquisition closed just days before the call, immediately framing the business as now operating under the combined structure with 61 new locations. Julio Ramirez and Mike Rabinovitch repeatedly reference 2021 developments that occurred after September 30—10 new restaurant openings including one in October, 15 additional Ghost Kitchens, 32 signed leases, and the acquisition itself—as already-real activity driving the current state.
ADSE · Q4 2021 → YESThe question is: Is there a clear gap between the trailing period being reported and the level at which the business is already operating right now, such that management describes a company that has a...YES The transcript shows a clear gap. Management repeatedly frames the company as already operating at a higher level than the 2021 print: a €60 million+ order backlog (explicitly “year-to-date” and “just completed Q1”), U.S. business launched in late 2021 with “initial success … world orders received,” a signed ChargePost contract for 50 units with plans for >10,000 more, U.S. manufacturing plant search already underway with opening expected this year, service contracts expected to start in 2022, and new hires completed.
BFIN · Q1 2022 → YESThe question is whether there's a clear gap between the trailing period being reported (Q1 2022) and the current operating level, as described by management. YES The transcript shows management explicitly updating on April activity as already real and substantial, with loan growth hitting $45 million in April alone (pushing the portfolio over $1.1 billion), Equipment Finance originating more in April than the entire Q1, and overall originations at $148 million in April.